Bonnie P. Taylor

1.1k total citations
17 papers, 706 citations indexed

About

Bonnie P. Taylor is a scholar working on Cognitive Neuroscience, Pharmacology and Clinical Psychology. According to data from OpenAlex, Bonnie P. Taylor has authored 17 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cognitive Neuroscience, 8 papers in Pharmacology and 5 papers in Clinical Psychology. Recurrent topics in Bonnie P. Taylor's work include Autism Spectrum Disorder Research (9 papers), Treatment of Major Depression (7 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Bonnie P. Taylor is often cited by papers focused on Autism Spectrum Disorder Research (9 papers), Treatment of Major Depression (7 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Bonnie P. Taylor collaborates with scholars based in United States, Australia and Ireland. Bonnie P. Taylor's co-authors include Frederic M. Quitkin, Jonathan W. Stewart, Patrick J. McGrath, Eric Hollander, Casara Jean Ferretti, Gerard E. Bruder, Eva Petkova, C.M.E. Kremer, Donald F. Klein and Ying Chen and has published in prestigious journals such as American Journal of Psychiatry, The British Journal of Psychiatry and The Journal of Clinical Psychiatry.

In The Last Decade

Bonnie P. Taylor

16 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bonnie P. Taylor United States 12 310 303 224 170 115 17 706
Metten Somers Netherlands 14 109 0.4× 453 1.5× 199 0.9× 90 0.5× 62 0.5× 31 807
Alexandra Schosser Austria 15 221 0.7× 105 0.3× 209 0.9× 88 0.5× 89 0.8× 36 685
G. Camuri Italy 14 245 0.8× 139 0.5× 374 1.7× 96 0.6× 57 0.5× 28 743
Tracy Waldeck United States 10 255 0.8× 361 1.2× 183 0.8× 237 1.4× 35 0.3× 10 994
M.-C. Bourdel France 15 185 0.6× 270 0.9× 280 1.3× 111 0.7× 131 1.1× 29 891
Alessandro Pigoni Italy 15 86 0.3× 184 0.6× 241 1.1× 86 0.5× 54 0.5× 44 617
Adham Mancini‐Marïe Canada 17 68 0.2× 356 1.2× 486 2.2× 113 0.7× 91 0.8× 42 926
Andrea Dlugos United States 14 221 0.7× 135 0.4× 105 0.5× 78 0.5× 50 0.4× 17 731
Monica Bosi Italy 10 96 0.3× 111 0.4× 232 1.0× 144 0.8× 103 0.9× 22 735
A. Gönenç United States 15 270 0.9× 362 1.2× 212 0.9× 170 1.0× 41 0.4× 26 811

Countries citing papers authored by Bonnie P. Taylor

Since Specialization
Citations

This map shows the geographic impact of Bonnie P. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bonnie P. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bonnie P. Taylor more than expected).

Fields of papers citing papers by Bonnie P. Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bonnie P. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bonnie P. Taylor. The network helps show where Bonnie P. Taylor may publish in the future.

Co-authorship network of co-authors of Bonnie P. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Bonnie P. Taylor. A scholar is included among the top collaborators of Bonnie P. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bonnie P. Taylor. Bonnie P. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ferretti, Casara Jean, Benjamin Lê Cook, Philip Chu, et al.. (2024). Cognitive inflexibility and immunome biomarkers in children with autism spectrum disorder. Neuroscience Applied. 3. 104071–104071. 1 indexed citations
2.
Ferretti, Casara Jean, et al.. (2021). Potential of cannabinoids as treatments for autism spectrum disorders. Journal of Psychiatric Research. 137. 194–201. 13 indexed citations
3.
Schwartz, Lauren, Assumpta Caixàs, Anastasia Dimitropoulos, et al.. (2021). Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium. Journal of Neurodevelopmental Disorders. 13(1). 25–25. 43 indexed citations
4.
Hollander, Eric, et al.. (2020). Intranasal oxytocin versus placebo for hyperphagia and repetitive behaviors in children with Prader-Willi Syndrome: A randomized controlled pilot trial. Journal of Psychiatric Research. 137. 643–651. 33 indexed citations
5.
Hollander, Eric, Genoveva Uzunova, Bonnie P. Taylor, et al.. (2018). Randomized crossover feasibility trial of helminthic Trichuris suis ova versus placebo for repetitive behaviors in adult autism spectrum disorder. The World Journal of Biological Psychiatry. 21(4). 291–299. 12 indexed citations
6.
Hollander, Eric, et al.. (2016). IMPULSIVITY AND COMPULSIVITY: TRANSLATIONAL APPROACHES TO COMPULSIVITY IN AUTISM SPECTRUM DISORDERS. European Neuropsychopharmacology. 26(5). 889–890. 4 indexed citations
7.
Ferretti, Casara Jean, et al.. (2016). HYPERTHERMIA AND THE IMPROVEMENT OF ASD SYMPTOMS. European Neuropsychopharmacology. 26(5). 890–891. 2 indexed citations
8.
Hollander, Eric, et al.. (2016). TRICHURIS SUIS OVA (TSO) AS AN IMMUNE-INFLAMMATORY TREATMENT FOR REPETITIVE BEHAVIORS IN ASD. European Neuropsychopharmacology. 26(5). 891–891. 1 indexed citations
9.
Hollander, Eric, et al.. (2014). P.7.d.006 Trichuris Suis Ova (TSO) as an immune-inflammatory treatment for repetitive behaviors in autism spectrum disorders (ASD). European Neuropsychopharmacology. 24. S723–S723. 2 indexed citations
10.
Hollander, Eric, Latha Soorya, William F. Chaplin, et al.. (2011). A Double-Blind Placebo-Controlled Trial of Fluoxetine for Repetitive Behaviors and Global Severity in Adult Autism Spectrum Disorders. American Journal of Psychiatry. 169(3). 292–299. 131 indexed citations
11.
Gorlyn, Marianne, John G. Keilp, Michael F. Grunebaum, et al.. (2008). Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects. Journal of Neural Transmission. 115(8). 1213–1219. 70 indexed citations
12.
Taylor, Bonnie P., Gerard E. Bruder, Jonathan W. Stewart, et al.. (2006). Psychomotor Slowing as a Predictor of Fluoxetine Nonresponse in Depressed Outpatients. American Journal of Psychiatry. 163(1). 73–78. 89 indexed citations
13.
Quitkin, Frederic M., Patrick J. McGrath, Jonathan W. Stewart, et al.. (2005). Remission Rates With 3 Consecutive Antidepressant Trials. The Journal of Clinical Psychiatry. 66(6). 670–676. 32 indexed citations
14.
Quitkin, Frederic M., Eva Petkova, Patrick J. McGrath, et al.. (2003). When Should a Trial of Fluoxetine for Major Depression Be Declared Failed?. American Journal of Psychiatry. 160(4). 734–740. 77 indexed citations
15.
Quitkin, Frederic M., Jonathan W. Stewart, Patrick J. McGrath, et al.. (2002). Are There Differences Between Women’s and Men’s Antidepressant Responses?. American Journal of Psychiatry. 159(11). 1848–1854. 107 indexed citations
16.
Quitkin, Frederic M., Bonnie P. Taylor, & C.M.E. Kremer. (2001). Does Mirtazapine Have a More Rapid Onset Than SSRIs?. The Journal of Clinical Psychiatry. 62(5). 358–361. 60 indexed citations
17.
Quitkin, F M, Patrick J. McGrath, J W Stewart, et al.. (1998). Placebo run-in period in studies of depressive disorders. The British Journal of Psychiatry. 173(3). 242–248. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026